ASX Filings

Initial Director's Interest Notice-JR

June 7, 2021

Opthea Appoints Julia A. Haller, MD, and Judith Robertson to Board of Directors

June 1, 2021

Additional Formats

PDF Version

Change in substantial holding

May 25, 2021

Becoming a substantial holder

April 28, 2021

Opthea Company Secretary Resignation

April 6, 2021

Additional Formats

PDF Version

Opthea Receives FDA Waiver for Pediatric Study Plan for OPT-302 in Wet AMD

March 31, 2021

Additional Formats

PDF Version

Change in substantial holding

March 26, 2021

Appendix 2A

March 25, 2021

Appendix 2A Update

March 25, 2021

Proposed issue of Securities - OPT

March 25, 2021